Benuvia Therapeutics

Benuvia Therapeutics Inc. focuses on financing and advancing low-risk assets with high clinical significance to enhance the quality of life for patients suffering from rare and underserved ailments. We are looking for collaborations to aid in the late-stage development and commercialization of our product pipeline. In the U.S., Benuvia markets SYNDROS®, an FDA-approved cannabinoid medication. Additionally, we operate a cutting-edge Research & Development and cGMP manufacturing facility through our affiliate, Benuvia Manufacturing.